Good MorningEquity markets advanced for the third consecutive day and the fifth of seven on Wednesday as investors adjust to the reality of Trump. The S&P 500 gained about 0.75% for the day to close near record highs. Earnings drive the move, in addition to Trump policies, including a report from Procter & Gamble. Procter & Gamble reported better-than-expected results on increased organic demand, showing consumer strength across a broad range of verticals.
Results from med tech Intuitive Surgical, rail carriers Union Pacific and CSX, and consumer Staple McCormick & Company will drive Thursday's action. All are expected to report growth and give positive guidance, potentially driving the S&P 500 to a new all-time high. The next major market hurdles will come in a week when the FOMC issues its January policy statement on Wednesday and the December PCE report is released on Friday. Featured: Free today: My 7-point options checklist (Ad) 
|
Medical | |
MaxCyte Inc. (NASDAQ: MXCT) is a global developer of next-generation cell therapies. They provide crucial technology for cell and gene therapies. Their core ExPERT ATx, sTX, GTx, and VLx tools use their proprietary technology called Flow Electroporation, which has been optimized for safe and eff... Read the Full Story |
|
From Our Partners | | The government just committed $200 billion to building computer chips on American soil - one of the largest technology bets in U.S. history.
George Gilder, who has tracked technology signals for over 40 years, believes Washington just tipped its hand. He says this move points to a coming shift in computing that could leave today's machines behind - and most investors have already moved past the headline. | | See the signal George Gilder is reading before the market catches on |
|
Consumer Staples | |
Insider activity is seldom enough to move a market independently but can signal how a company’s management thinks. Those signals become strong when the institutional and analysts' activity aligns with them, more substantial forces capable of sustaining upward movement in a stock’s pric... Read the Full Story |
|
Technology | |
Oracle’s (NYSE: ORCL) game-changing news isn’t centered on a single event but rather a series that culminates in forming The Stargate Project. The Stargate Project is a new joint venture between OpenAI and Softbank intended to build next-gen AI-focused data centers in the United Stat... Read the Full Story |
|
From Our Partners | | When the railroads launched in the 1860s, Andrew Carnegie didn't profit by riding the trains - he got rich owning the steel rails they ran on. The same dynamic may be playing out today around the anticipated $1.75 trillion SpaceX IPO.
Analyst Michael Robinson has identified a tiny, under-the-radar supplier - just 1/60th the size of SpaceX - that he believes sits at the center of Elon Musk's broader AI infrastructure buildout. | | Watch Robinson's presentation and see the details before the IPO window closes |
|
Consumer Discretionary | |
Netflix (NASDAQ: NFLX) completely shattered analyst expectations in its latest earnings report, sending shares up over 14% in after-hours trading on Jan. 21. The consumer discretionary company's subscribers grew by an incredible 19 million. This helped the stock rise above its late 2024 all-time... Read the Full Story |
|
Medical | |
Shares of Tempus AI Inc. (NASDAQ: TEM) surged 35% on Tuesday, bringing its market capitalization to $7.5 billion. The rally was driven by headline-grabbing news and strong market sentiment, underscoring the company’s leadership in integrating artificial intelligence (AI) into healthcare. S... Read the Full Story |
|
From Our Partners | | Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge.
Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks.
Stream his free presentation to get every buy and sell recommendation with no membership or credit card required. | | Watch Marc Chaikin's free presentation and get his full buy-and-sell list today |
|
Technology | |
The latest filings show Representative Nancy Pelosi (D-CA), the most active large investor in the U.S. Congress, betting big on AI. Her latest trades include significant new positions in Google parent Alphabet (NASDAQ: GOOGL) and Amazon (NASDAQ: AMZN), repositioning in NVIDIA (NASDAQ: NVDA), a thi... Read the Full Story |
|
Auto/Tires/Trucks | |
Mobileye (NASDAQ: MBLY) short interest remains high and has the stock set up for a squeeze. At 20%, the short interest rate is sufficiently high to drive a significant upside in the price action; all it will take is good news, and there is reason to believe it will come in 2025.
Automobile sale... Read the Full Story |
|
Auto/Tires/Trucks | |
The electric vehicle (EV) market is a hotbed of innovation and investment but also a space filled with uncertainty and risk. Rivian Automotive (NASDAQ: RIVN) is a prominent player in this expanding industry, and the company has experienced a rollercoaster ride in its stock price over the past fe... Read the Full Story |
|
Basic Materials | |
Coming up with a great trade idea is easier than most investors think. They just need to get their hands on the right tools and datasets to arrive at said ideas. After that, it all comes down to managing the price action that comes after placing the idea. Today, investors have a chance to reverse ... Read the Full Story |
|
Medical | |
The advent of GLP-1 treatments has been a game changer in the medical sector for weight loss and chronic obesity. The GLP-1 market is currently dominated by semaglutide (Ozempic and Wegovy) produced by Novo Nordisk A/S (NYSE: NVO) and tirzepatide (Mounjaro and Zepbound) produced by Eli Lilly and C... Read the Full Story |
|
Thursday's Early Bird Stock Of The Day Sprouts Farmers Market, Inc., together with its subsidiaries, engages in the retailing of fresh, natural, and organic food products under the Sprouts brand in the United States. It offers perishable product categories, including fresh produce, meat and meat alternatives, seafood, deli, bakery, floral, and dairy and dairy alternatives; and non-perishable product categories, such as grocery, vitamins and supplements, bulk items, frozen foods, beer and wine, and natural health and body care. Sprouts Farmers Market, Inc. was founded in 1943 and is headquartered in Phoenix, Arizona. | | View Today's Stock Pick |
|
